Novel Business Models Supported by Virtual Care Technologies that Offer Direct Patient Support will Emerge Over the Next 2-3 Years
06-Jul-2021
North America
Market Research
MG02-01-00-00-00
HC03429-NA-MT_25559
The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”. Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health. Mass unemployment, salary reductions, depleting financial security nets, increasing domestic violence, homelessness, and poverty are gaining prevalence due to ending lockdowns and other stringent norms. This is resulting in stress, anxiety, depression, and other mental health conditions, which is leading to an overall reduction in quality of life and is linked to a rising number of suicides and a general feeling of morbidity. The despair does not end there. Mental and substance disorders cause lower productivity; the WHO noted that depression and anxiety have cost the global economy an estimated $1 trillion per year in lost productivity. Patients are running out of prescription medication for their mental health conditions. In several countries, including India, getting medication without a prescription is a challenge, and patients have to rely on considerate pharmacists to refill their medication. Telepsychiatry and virtual mental health care are taking off. 2020 saw record funding for mental health start-ups. Virtual mental healthcare vendors, especially in the United States, saw a surge in bookings, and they are making efforts to meet demand by introducing new services, accelerating launch timelines, and hiring more staff. The pandemic has pushed the adoption of technology for various use-cases. While the use of virtual consultations for mental health may slow down when the pandemic subsides, it will continue to be higher than pre-COVID times. In addition to fast-tracking the launches of their services and demonstrating their ability to scale-up, telepsychiatry service providers must have fluid business models based on variable, rather than fixed, costs to manage fluctuating demand. This Frost & Sullivan study decodes the digital health landscape for behavioral health management solutions. It also analyzes the growth opportunities arising from the use of digital health tools such as iCBT, telepsychiatry, enterprise tools, connected sensor-based devices, and AI and analytics-based solutions.
Author: Chandni Mathur
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Use of Digital Health Solutions in the Behavioral Health Management Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Key Findings
Definition and Segmentation
Connected and Quantified Patients will Lay the Foundation for New Solution Design
Moving from Products to Services in Behavioral Health Management
Application of Mental Health Technology in the Care Continuum
Conceptual Framework of the Causal and Protective Factors that Affect Mental Health
COVID-19 and Mental Health
COVID-19 and Mental Health (continued)
Health Systems’ Priorities for the Immediate Future
The Golden Age of Mental Health Technology
Product/Service Lifecycle Analysis
Mental Health Issues in Women
Digital Therapeutics (DTx) in Mental Health
Key Digital Therapeutics Vendors
Key Trends
Regulatory Considerations for Behavioral Health
Competitive Environment
Key Competitors
Opportunity Assessment
Business Models
Mapping of Business Models to Solution Segments
Business-to-Consumer/Direct-to-Consumer Business Model
B2B—Self-Insured Employer Model
B2B—Fee-for-Service Model (health system and payors)
B2B—Value-based Healthcare Service Models (health system and payors)
B2B—Regulatory Approval for Reimbursement (health systems and payors)
Key Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast, Digital Solutions for Behavioral Health Management
Revenue Forecast Analysis, Digital Solutions for Behavioral Health Management
Revenue Forecast by Segment, Digital Solutions for Behavioral Health Management
Revenue Forecast Analysis by Segment, Digital Solutions for Behavioral Health Management
Revenue Forecast by Region, Digital Solutions for Behavioral Health Management
Revenue Forecast Analysis by Region, Digital Solutions for Behavioral Health Management
Key Growth Metrics for iCBT
Revenue Forecast, iCBT
Revenue Forecast Analysis, iCBT
Key Growth Metrics for Telepsychiatry
Revenue Forecast, Telepsychiatry
Revenue Forecast Analysis, Telepsychiatry
Key Growth Metrics for Enterprise Tools
Revenue Forecast, Enterprise Tools
Revenue Forecast Analysis, Enterprise Tools
Key Growth Metrics for Connected Sensor-based Devices
Revenue Forecast, Connected Sensor-based Devices
Revenue Forecast Analysis, Connected Sensor-based Devices
Key Growth Metrics for AI and Analytics-based Solutions
Revenue Forecast, AI and Analytics-based Solutions
Revenue Forecast Analysis, AI and Analytics-based Solutions
Growth Opportunity 1—Behavioral Health Solutions for the Pediatric Population, 2021
Growth Opportunity 1—Behavioral Health Solutions for the Pediatric Population, 2021 (continued)
Growth Opportunity 2—Behavioral Health Solutions for Hospital Staff, 2021
Growth Opportunity 2—Behavioral Health Solutions for Hospital Staff, 2021 (continued)
Growth Opportunity 3—Development and Use of Technology Solutions to Target Substance Abuse and Addiction Management, 2021
Growth Opportunity 3—Development and Use of Technology Solutions to Target Substance Abuse and Addiction Management, 2021 (continued)
Growth Opportunity 4—Clinical Decision Support Tools for Clinical Efficiency Improvements, 2021
Growth Opportunity 4—Clinical Decision Support Tools for Clinical Efficiency Improvements, 2021 (continued)
Growth Opportunity 5—Single Platform that Offers a Mix of Digital Solutions, 2021
Growth Opportunity 5—Single Platform that Offers a Mix of Digital Solutions, 2021 (continued)
Growth Opportunity 6—Sensors to Enhance Assessment and Treatment, 2021
Growth Opportunity 6—Sensors to Enhance Assessment and Treatment, 2021 (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Digital Health research
06 Oct 2026 | Global | Technology Research
Trends in Laboratory Automation, Global, 2021–2025
This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metaboli...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Chandni Mathur |
| Industries | Healthcare |
| WIP Number | MG02-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9564-B1,9575-B1,9600-B1,9612-B1,9825-B1,9A56-B1,9A06-B1,9A55-B1,9AD7-B1,99BB-B1,99BC-B1,99BD-B1 |
Global Digital Health Solutions for Behavioral Health Management Growth Opportunities
$4,950.00
Special Price $3,712.50 save 25 %